Company intelligence / Profile preview

Changzhou Pharmaceutical Factory

Changzhou, Jiangsu, Chinaczpharma.com ↗

Ownership: Private
Employees: ~1500
Development stage: Commercial

Overview

Changzhou Pharmaceutical Factory is a leading Chinese pharmaceutical manufacturer with a strong focus on cardiovascular medicines, complex generics, APIs, and finished formulations. The company has multiple products approved by US FDA, EUGMP, PMDA, and CFDA audits. It exports to over fifty countries and collaborates with major global pharma companies.

Therapeutic areas: GastroenterologyCardiovascularEndocrinologyInfectious Diseases
Modalities: Small moleculeBiologic (for some finished formulations and sterile injectables)
Industry: Biotech

Drug pipeline

5 assets

apremilast

Commercial

Indications: Plaque psoriasis

4 more assets in the full pipeline.

Request access →

Partnerships

NovartisSanofiGSKMerckRochePfizerTEVAApotexSun Pharma

Beyond the preview

Go deeper on Changzhou Pharmaceutical Factory.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Changzhou Pharmaceutical Factory.

Explore the full profile